These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Endothelin receptor antagonists--a brief description of the new class of drugs]. Kowalczyk A; Kołodziejczyk M; Gorąca A Postepy Hig Med Dosw (Online); 2014 Jan; 68():1076-80. PubMed ID: 25228516 [TBL] [Abstract][Full Text] [Related]
14. Endothelin antagonists in clinical trials: lessons learned. Barton M; Kohan DE Contrib Nephrol; 2011; 172():255-260. PubMed ID: 21894005 [TBL] [Abstract][Full Text] [Related]
15. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure. Pfab T; Thöne-Reineke C; Theilig F; Lange I; Witt H; Maser-Gluth C; Bader M; Stasch JP; Ruiz P; Bachmann S; Yanagisawa M; Hocher B J Am Soc Nephrol; 2006 Apr; 17(4):1082-9. PubMed ID: 16495378 [TBL] [Abstract][Full Text] [Related]
16. Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension. Miyagawa K; Emoto N Ther Adv Cardiovasc Dis; 2014 Oct; 8(5):202-16. PubMed ID: 24990369 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelin in hypertension. Schiffrin EL Vascul Pharmacol; 2005 Jun; 43(1):19-29. PubMed ID: 15955745 [TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition? Jacobs A; Preston IR; Gomberg-Maitland M Curr Med Res Opin; 2006 Dec; 22(12):2567-74. PubMed ID: 17166339 [TBL] [Abstract][Full Text] [Related]
19. Endothelin and tubulointerstitial renal disease. Ong AC; von Websky K; Hocher B Semin Nephrol; 2015 Mar; 35(2):197-207. PubMed ID: 25966351 [TBL] [Abstract][Full Text] [Related]
20. Endothelin, nitric oxide, and reactive oxygen species in diabetic kidney disease. Pollock JS; Pollock DM Contrib Nephrol; 2011; 172():149-159. PubMed ID: 21893996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]